Following AI imaging screening, AI pathology analysis or medical AI breakthrough new direction. Tencent recently held hands with Huayin Health. The two sides signed a strategic cooperation agreement on “medical artificial intelligence development project†to promote the development and application of AI pathology technology. This means that Tencent's research in the field of medical AI has entered the pathological analysis stage from image screening. This cooperation is also the contractor of Tencent as the new generation artificial intelligence open innovation platform for medical imaging, driving the positive practice of the development and application of medical AI industry.
A new breakthrough in medical AI - from imaging screening to pathological analysis
Clinically, pathological analysis is the "gold standard" for diagnosis, prognosis analysis and guiding cancer treatment. As a key link in the medical chain, pathological diagnosis of patients is an important basis for doctors to judge the nature of tumors. The diagnosis is also the cornerstone of the doctor's "prescription for the disease" and subsequent treatment. Therefore, improving the efficiency and accuracy of pathological diagnosis is crucial for the development of precision medicine .
According to reports, Tencent will deeply integrate technology and medicine, rely on Huayin's healthy massive clinical pathological resources, use its own image recognition, big data processing, deep learning and other leading AI technologies to structure pathological data and build a pathological big data system. To achieve effective mining of data, research and development of AI pathology products and promote the application of technology. At the same time, the project will also establish a team of project experts covering well-known pathologists and clinical experts at home and abroad to provide a professional talent base for technology research and development and application.
Digitizing the pathological sections and assisting the analysis with the AI ​​algorithm, this intelligent medical model will effectively improve the diagnostic efficiency of doctors and alleviate the shortage of pathologists. Based on AI pathology studies, personalized treatment and prognosis assessments will also be possible. From image screening to pathological analysis, Tencent's multimodality in clinical diagnosis has gradually been established, providing clinicians with more auxiliary diagnostic tools and multi-modality as a doctor's clinical diagnostic "helper."
Open cooperation promotes continuous innovation of medical AI
Based on Tencent's technological breakthroughs in the field of medical AI, in November last year, Tencent was approved to build a new generation of artificial intelligence open innovation platform for medical imaging. Since Tencent has built a new generation of artificial intelligence open innovation platform for medical imaging, it has always insisted on opening up a variety of capabilities, and promoted the national artificial intelligence strategy in the medical field from the four dimensions of innovation and entrepreneurship, industry chain cooperation, academic research, and HP public welfare. The cooperation with Huayin Health is Tencent's active practice in driving the development and application of the medical AI industry as a “national teamâ€, and jointly promotes the interdisciplinary research in the field of medical AI, and promotes a variety of research in the field of medical AI. Form, integrate resources from both sides, and promote innovative breakthroughs in AI pathology.
In the future, Tencent will also deepen its medical field and further open up its technology and cooperation resources, open up the medical AI innovation chain, build an open and win-win Internet + medical new ecology, and work with many partners to promote the innovation of artificial intelligence technology in the medical field. Application, let AI go deep into the clinical line, solve medical problems, promote the balanced development of medical resources and service capabilities, and promote industrial change.
Calcium Acetate Monohydrate,Calcium Acetate,Calcium Acetate Powder,Calcium Ethanoic Acid Salt
Wuxi Yangshan Biochemical Co.,Ltd. , https://www.yangshanchem.com